Gilead

Page 4 of 4

FRANCE-ECONOMY-PHARMACEUTICALS-SANOFI
Health

Sanofi Just Went Hostile in Its Medivation Takeover Bid

By
May 25, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
Finance

Biotech Stocks Are Down 25% So Far This Year

By
May 6, 2016
Technology That Helps
Tech

This Patch Could Be a Great Hack for People With Heart Problems

By
April 24, 2016
Inside of a Gilead Sciences Lab
Health

The FDA Just Approved Another Next-Gen Gilead HIV Drug

By
April 5, 2016
Inside of a Gilead Sciences Lab
Health

Gilead Ordered to Pay Merck $200 Million in Hepatitis C Dispute

By
March 25, 2016
117046657
Health

Gilead May Have to Pay Rival Merck Billions in Royalties

By
March 23, 2016
Key Speakers At The Stanford Institute For Economic Policy Research Forum
Leadership

Gilead CEO John Martin Is Stepping Down After 20 Years

By
January 29, 2016
Hottest companies on the Fortune 500
Leadership

Hottest companies on the Fortune 500

By
June 5, 2015
John Martin, Gilead Science CEO
Health

John Martin: Gilead’s disease hunter

By
May 23, 2011

Most Popular